BNP Paribas Financial Markets’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.8K | Sell |
9,667
-91
| -0.9% | -$587 | ﹤0.01% | 4589 |
|
|
2025
Q4 | $58.1K | Buy |
9,758
+1,702
| +21% | +$9.04K | ﹤0.01% | 4612 |
|
|
2025
Q3 | $42.8K | Buy |
8,056
+2,290
| +40% | +$9.71K | ﹤0.01% | 4661 |
|
|
2025
Q2 | $19.8K | Sell |
5,766
-71,562
| -93% | -$228K | ﹤0.01% | 4614 |
|
|
2025
Q1 | $229K | Buy |
77,328
+3,027
| +4% | +$9.47K | ﹤0.01% | 3621 |
|
|
2024
Q4 | $227K | Buy |
74,301
+6,599
| +10% | +$19.2K | ﹤0.01% | 3794 |
|
|
2024
Q3 | $173K | Buy |
67,702
+64,482
| +2,003% | +$195K | ﹤0.01% | 3305 |
|
|
2024
Q2 | $10.5K | Buy |
3,220
+2,978
| +1,231% | +$13.1K | ﹤0.01% | 3718 |
|
|
2024
Q1 | $1.28K | Hold |
242
| – | – | ﹤0.01% | 3846 |
|
|
2023
Q4 | $1.05K | Hold |
242
| – | – | ﹤0.01% | 3848 |
|
|
2023
Q3 | $636 | Hold |
242
| – | – | ﹤0.01% | 3775 |
|
|
2023
Q2 | $854 | Hold |
242
| – | – | ﹤0.01% | 3774 |
|
|
2023
Q1 | $748 | Hold |
242
| – | – | ﹤0.01% | 3699 |
|
|
2022
Q4 | $1.02K | Sell |
242
-19,676
| -99% | -$67.9K | ﹤0.01% | 3801 |
|
|
2022
Q3 | $47.2K | Buy |
19,918
+6,212
| +45% | +$18.1K | ﹤0.01% | 3991 |
|
|
2022
Q2 | $39.1K | Buy |
13,706
+2,369
| +21% | +$5.89K | ﹤0.01% | 3608 |
|
|
2022
Q1 | $32.7K | Sell |
11,337
-17
| -0.1% | -$44 | ﹤0.01% | 3646 |
|
|
2021
Q4 | $34.5K | Buy |
11,354
+4,447
| +64% | +$19.3K | ﹤0.01% | 3797 |
|
|
2021
Q3 | $48.4K | Buy |
6,907
+5,598
| +428% | +$41.9K | ﹤0.01% | 3523 |
|
|
2021
Q2 | $12K | Sell |
1,309
-6,308
| -83% | -$63.9K | ﹤0.01% | 3679 |
|
|
2021
Q1 | $74K | Sell |
7,617
-123,233
| -94% | -$1.38M | ﹤0.01% | 3484 |
|
|
2020
Q4 | $1.34M | Buy |
130,850
+123,349
| +1,644% | +$1.25M | ﹤0.01% | 1834 |
|
|
2020
Q3 | $75.7K | Sell |
7,501
-2,005
| -21% | -$20.4K | ﹤0.01% | 3263 |
|
|
2020
Q2 | $99.1K | Sell |
9,506
-27,909
| -75% | -$289K | ﹤0.01% | 2767 |
|
|
2020
Q1 | $316K | Buy |
37,415
+33,141
| +775% | +$322K | ﹤0.01% | 2611 |
|
|
2019
Q4 | $37.4K | Sell |
4,274
-12,285
| -74% | -$102K | ﹤0.01% | 3799 |
|
|
2019
Q3 | $178K | Sell |
16,559
-642
| -4% | -$6.93K | ﹤0.01% | 2816 |
|
|
2019
Q2 | $219K | Buy |
17,201
+6,214
| +57% | +$143K | ﹤0.01% | 2563 |
|
|
2019
Q1 | $426K | Buy |
10,987
+5,996
| +120% | +$183K | ﹤0.01% | 2199 |
|
|
2018
Q4 | $102K | Buy |
4,991
+1,296
| +35% | +$38.9K | ﹤0.01% | 2347 |
|
|
2018
Q3 | $169K | Buy |
3,695
+386
| +12% | +$18.6K | ﹤0.01% | 2480 |
|
|
2018
Q2 | $196K | Sell |
3,309
-96,686
| -97% | -$5.6M | ﹤0.01% | 2448 |
|
|
2018
Q1 | $6.8M | Buy |
99,995
+93,973
| +1,560% | +$7.04M | 0.01% | 857 |
|
|
2017
Q4 | $595K | Buy |
6,022
+2,417
| +67% | +$270K | ﹤0.01% | 2350 |
|
|
2017
Q3 | $432K | Buy |
3,605
+64
| +2% | +$5.95K | ﹤0.01% | 2063 |
|
|
2017
Q2 | $309K | Sell |
3,541
-19,530
| -85% | -$1.09M | ﹤0.01% | 2177 |
|
|
2017
Q1 | $858K | Buy |
23,071
+20,972
| +999% | +$765K | ﹤0.01% | 1437 |
|
|
2016
Q4 | $64.4K | Sell |
2,099
-34
| -2% | -$1.47K | ﹤0.01% | 2722 |
|
|
2016
Q3 | $143K | Buy |
2,133
+1,127
| +112% | +$57K | ﹤0.01% | 1920 |
|
|
2016
Q2 | $30K | Buy |
1,006
+620
| +161% | +$19.4K | ﹤0.01% | 2450 |
|
|
2016
Q1 | $11.3K | Sell |
386
-378
| -49% | -$17.1K | ﹤0.01% | 2211 |
|
|
2015
Q4 | $59.9K | Sell |
764
-31,041
| -98% | -$2.44M | ﹤0.01% | 2682 |
|
|
2015
Q3 | $2.4M | Buy |
31,805
+29,976
| +1,639% | +$2.83M | 0.01% | 820 |
|
|
2015
Q2 | $214K | Buy |
1,829
+1,277
| +231% | +$231K | ﹤0.01% | 1685 |
|
|
2015
Q1 | $130K | Buy |
+552
| New | +$118K | ﹤0.01% | 1671 |
|
|
2014
Q4 | – | Sell |
-1,359
| Closed | -$324K | – | 2855 |
|
|
2014
Q3 | $324K | Buy |
1,359
+1,286
| +1,762% | +$264K | ﹤0.01% | 1684 |
|
|
2014
Q2 | $4.82K | Buy |
+73
| New | +$5.19K | ﹤0.01% | 2605 |
|
|
2014
Q1 | – | Sell |
-286
| Closed | -$29.6K | – | 3708 |
|
|
2013
Q4 | $29.6K | Sell |
286
-5,708
| -95% | -$335K | ﹤0.01% | 2085 |
|
|
2013
Q3 | $322K | Sell |
5,994
-2,864
| -32% | -$154K | ﹤0.01% | 1870 |
|
|
2013
Q2 | $393K | Buy |
+8,858
| New | +$312K | ﹤0.01% | 1759 |
|
Other funds holding PBYI
ACA
VCM
VPM
BNP Paribas Financial Markets's PBYI Position: Q1 2026 in Review
BNP Paribas Financial Markets reduced its Puma Biotechnology (PBYI) stake by 0.93% in Q1 2026, selling an estimated $587 and leaving 9,667 shares worth $61.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4589.
BNP Paribas Financial Markets first reported a position in PBYI in Q2 2013 and has held it in 50 quarters since. The position peaked at $6.8M in Q1 2018. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.
- BNP Paribas Financial Markets held 9,667 shares of Puma Biotechnology worth $61.8K as of Q1 2026.
- BNP Paribas Financial Markets sold 91 Puma Biotechnology shares in Q1 2026, an estimated $587.
- Puma Biotechnology made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4589 holding.
- BNP Paribas Financial Markets first reported a position in Puma Biotechnology in Q2 2013 and has held it in 50 quarters since.
- BNP Paribas Financial Markets's Puma Biotechnology position peaked at $6.8M in Q1 2018.
- 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.